RDUS wayyy oversold on news of new CEO - sell puts/enter!
RDUS still maintains analyst buys/PT of >60 wth their new approved drug, Tymlos which will start selling later this year (hopefully) and has strong advantages over current Forteo. Nevertheless, the market wayyyy overreacted to news of a new CEO & look at the RSI now! I just wrote Jan 2018 35 puts and about to write July & Aug. 40s for easy premium or cheap shares (couldn't resist despite being farther out than i normally write them)...DEF recommend selling puts on this one or grabbing your first 1/3 position for easy swing or hold back to 50 in short order!
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.